News Focus
News Focus
Followers 280
Posts 31200
Boards Moderated 0
Alias Born 07/06/2012

Re: John_Langston post# 191279

Sunday, 03/27/2016 9:52:08 PM

Sunday, March 27, 2016 9:52:08 PM

Post# of 444373
Yeah Nasrat looks real worried. LMAO

The FDA's decision to grant Priority Review to the SequestOxTM submission is an important milestone for Elite and an important step toward providing a new treatment option for physicians and patients that may deter some of the common methods of opioid abuse," said Nasrat Hakim, President and Chief Executive Officer of Elite. "I am pleased with the targeted PDUFA date and we look forward to the FDA's review of our submission."

Fear Uncertainty and Doubt FUD It Ain't Going To Work Here Anymore. Notice the lack of question mark.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News